ArticleOncoTargets and therapy2018

Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer.

Pamela Salman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.